
Study AS-I
Articles
-
Oct 17, 2024 |
rxlist.com | Study AS-I |John P. Cunha
What Is Abrilada? Abrilada (adalimumab-afzb) is a tumor necrosis factor (TNF) blocker used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis and plaque psoriasis. Abrilada is biosimilar to Humira (adalimumab). What Are Side Effects of Abrilada?
-
Sep 4, 2024 |
rxlist.com | Study AS-I |John P. Cunha
What Is Yuflyma?
-
Sep 3, 2024 |
rxlist.com | Study AS-I |John P. Cunha
What Is Amjevita? Amjevita (adalimumab-atto) injection is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps). What Are Side Effects of Amjevita?
-
Sep 3, 2024 |
rxlist.com | Study AS-I
What Is Simlandi?
-
Jul 30, 2024 |
rxlist.com | Study AS-I
What Is Hyrimoz? Hyrimoz (adalimumab-adaz) is a tumor necrosis factor (TNF)-blocker biosimilar to Humira (adalimumab) indicated for treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis (UC), and plaque psoriasis. What Are Side Effects of Hyrimoz?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →